Skip to main content
PolicySpeak
← All files
PB

Pivot Bio

Company · United States · EU Transparency Register 046264946723-50

1
position filed
in the 665 files tracked
1
legislative file
of 665 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1210 companies & groups on this site, they rank #1104 by legislative files engaged, a count of participation, not a measure of influence.

0.2
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2022
in the register since

Declares membership of

  • Europa Bio →
  • US National Corn Growers Association
  • US National Sorghum Producers
  • US National Association of Wheat Growers
  • Iowa State Univeristy
  • NC State University
  • University of Illinois
  • Precision Planting

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).

Register category
Companies & groups
Registered as
Pivot Bio, Inc
Head office
Minnetonka, United states

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Pivot in PolicySpeak: request access →

Follow Pivot Bio

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at Pivot Bio? so we know who speaks for it.

Their record over time

Pivot Bio filed 1 position on 25 Jul 2026, across 1 of the 665 legislative files tracked here, attaching a full position paper 1 time.

What they argued

European Biotech Actfiled 25 Jul 2026PDFsource

701 Carlson Parkway, Suite 220 Minnetonka, MN 55305 July 25, 2026 Submitted electronically via Have Your Say Regarding: 1462 Biotech Act Subject: Feedback on public consultation by the European Commission’s (DG Sante) on Biotech Act I and the proposal for amending Directive 2001/18/EC for placing GMMs on the market I’m writing as a senior member of the team at Pivot Bio. Based in Minnesota, USA.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Pivot Bio next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Pivot Bio’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.